.png)
Agenzia Italiana del Farmaco
home
Highlights
-
03 Feb 2026
Press releases
Proton Pump Inhibitors (PPIs): AIFA introduces Note ‘N01’
A new Note will regulate the conditions for prescribing Proton Pump Inhibitors (PPIs) covered by the National Health Service.
-
30 Jan 2026
Press releases
Neglected tropical diseases: defending global health
‘Unite, Act and Eliminate’. To join forces, take action and eliminate neglected tropical diseases: this is the call relaunched by the WHO on World Neglected Tropical Diseases Day 2026. AIFA wholeheartedly supports this appeal.
-
29 Jan 2026
Press releases
AIFA monitoring of pharmaceutical expenditure January-September 2025
Expenditure on medicines dispensed through pharmacies open to the public amounted to €6,425 million (6.33% of the FSN), while expenditure on medicines purchased directly by public healthcare facilities amounted to €11,811 million (11.64% of the FSN).
-
06 Feb 2026
The Agency
AIFA in blu per la Giornata nazionale contro il bullismo e il cyberbullismo del 7 febbraio
In occasione della Giornata nazionale contro il bullismo e il cyberbullismo, che si celebra il 7 febbraio, anche l’AIFA intende contribuire alla doverosa riflessione pubblica sul fenomeno, soffermandosi sull’importanza di una risposta sanitaria appropriata e consapevole ai segnali di disagio, soprattutto in età evolutiva.
News
06 Feb 2026
Quality and Inspections
Direct communication with healthcare professionals on Arixtra (fondaparinux sodium)
03 Feb 2026
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 31 August 2025
15 Jan 2026
Transparency Lists
AIFA updates the Transparency Lists
14 Jan 2026
Companies Section
New Features of the Conference and Meeting Authorisation System
07 Jan 2026
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 31 July 2025
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
